# Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

> **NCT02309632** · NA · WITHDRAWN · sponsor: **University of Arkansas**

## Conditions studied

- Pancreatic Neoplasms
- Peutz-Jegher's Syndrome
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
- Ataxia Telangiectasia
- Familial Atypical Mole-Malignant Melanoma Syndrome
- Colorectal Neoplasms, Hereditary Nonpolyposis
- Hereditary Pancreatitis

## Interventions

- **OTHER:** Pancreatic Cancer Screening Pathway 1
- **OTHER:** Pancreatic Cancer Screening Pathway 2

## Key facts

- **NCT ID:** NCT02309632
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-11
- **Primary completion:** 2019-07-19
- **Final completion:** 2019-07-19
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2019-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02309632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02309632, "Pancreatic Cancer Screening of High-Risk Individuals in Arkansas". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02309632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*